NCT02374814View on ClinicalTrials.gov

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 24, 2015

Primary Completion Date

September 22, 2016

Study Completion Date

September 22, 2016

Conditions
Rabies
Interventions
DRUG

Rabies vaccine

Compare dose schedule and route of administration

DRUG

Placebo

Placebo

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

State University of New York - Upstate Medical University

OTHER

NCT02374814 - Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis | Biotech Hunter | Biotech Hunter